Development of Integrated Approaches to Testing and Assessment (IATA) case studies on developmental neurotoxicity (DNT) risk assessment

被引:35
作者
Hernandez-Jerez, Antonio
Adriaanse, Paulien
Aldrich, Annette
Berny, Philippe
Coja, Tamara
Duquesne, Sabine
Focks, Andreas
Marinovich, Marina
Millet, Maurice
Pelkonen, Olavi
Pieper, Silvia
Tiktak, Aaldrik
Topping, Christopher
Widenfalk, Anneli
Wilks, Martin
Wolterink, Gerrit
Crofton, Kevin
Hougaard Bennekou, Susanne
Paparella, Martin
Tzoulaki, Ioanna
机构
关键词
IATA; developmental neurotoxicity; DNT; AOP; Deltamethrin; Flufenacet; in vitro; evidence-; based; uncertainty analysis; PYRETHROID INSECTICIDE EXPOSURE; NEURODEVELOPMENTAL DISORDERS; PESTICIDE EXPOSURE; EPIDEMIOLOGY; CHILDREN;
D O I
10.2903/j.efsa.2021.6599
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The EFSA Panel on Plant Protection Products and their Residues (PPR) has developed, as a self-task mandate (EFSA-Q-2019-00100), two adverse outcome pathway (AOP)-informed integrated approach to testing and assessment (IATA) case studies to answer a developmental neurotoxicity (DNT) hazard identification and characterisation problem formulation that could support the regulatory decisions for the pesticide active substances deltamethrin and flufenacet. The IATA were developed to assess the applicability of the DNT in vitro testing battery (IVB), designed to explore fundamental neurodevelopmental processes, in the regulatory risk assessment of pesticides. For this purpose, an evidence-based-approach methodology was applied: 1) systematic literature review and critical appraisal of all the evidence i.e. human observational studies, in vivo data from rodent models and new approach methodologies (NAMs, i.e. in vitro studies including high-throughput testing from IVB and zebrafish studies from the literature) for both case studies; 2) a quantitative uncertainty analysis of all the evidence using expert knowledge elicitation (EKE) and a probabilistic approach; 3) integration of all the evidence using the AOP conceptual framework. This stepwise approach resulted in the postulation of an evidence-based AOP network for one of the case studies. A probabilistic quantification of the weight of evidence (WoE) using Bayesian network analysis allowed the assessment and the quantification of the uncertainty in the postulated AOP. The approach taken allowed conclusions to be drawn with an acceptable level of certainty in DNT hazard identification and characterisation of deltamethrin and that flufenacet is not a developmental neurotoxicant, supporting the relevance of the mechanistic understanding. The case studies show the applicability of the DNT-IVB for hazard identification and characterisation and illustrate the usefulness of an AOP-informed IATA for regulatory decision making. The overall activity led to improved interpretation of human data by providing a plausible mechanistic link to adverse outcomes, which would support their contextualisation in the risk assessment process. This Scientific Opinion allows the PPR Panel to draft several recommendations for the implementation of the AOP-informed IATA methodology and of the DNT-IVB in the regulatory risk assessment of pesticides. (C) 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
引用
收藏
页数:63
相关论文
共 50 条
  • [21] Low-level arsenic exposure and developmental neurotoxicity in children: A systematic review and risk assessment
    Tsuji, Joyce S.
    Garry, Michael R.
    Perez, Vanessa
    Chang, Ellen T.
    TOXICOLOGY, 2015, 337 : 91 - 107
  • [22] Developing Integrated Approaches for Testing and Assessment (IATAs) in order to support nanomaterial safety
    Powell, L. G.
    Gillies, S.
    Fernandes, T. F.
    Murphy, F.
    Giubilato, E.
    Cazzagon, V.
    Hristozov, D.
    Pizzol, L.
    Blosi, M.
    Costa, A. L.
    Prina-Mello, A.
    Bouwmeester, H.
    Sarimveis, H.
    Janer, G.
    Stone, V.
    NANOTOXICOLOGY, 2022, 16 (04) : 484 - 499
  • [23] Continuing Education Course #3: Current Practices and Future Trends in Neuropathology Assessment for Developmental Neurotoxicity Testing
    Bolon, Brad
    Garman, Robert H.
    Gundersen, Hans Jorgen G.
    Johnson, G. Allan
    Kaufmann, Wolfgang
    Krinke, Georg
    Little, Peter B.
    Makris, Susan L.
    Mellon, R. Daniel
    Sulik, Kathleen K.
    Jensen, Karl
    TOXICOLOGIC PATHOLOGY, 2011, 39 (01) : 289 - 293
  • [24] Developmental Neurotoxicity of Engineered Nanomaterials: Identifying Research Needs to Support Human Health Risk Assessment
    Powers, Christina M.
    Bale, Ambuja S.
    Kraft, Andrew D.
    Makris, Susan L.
    Trecki, Jordan
    Cowden, John
    Hotchkiss, Andrew
    Gillespie, Patricia A.
    TOXICOLOGICAL SCIENCES, 2013, 134 (02) : 225 - 242
  • [25] Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: Behavioral effects
    Cory-Slechta, DA
    Crofton, KM
    Foran, JA
    Ross, JF
    Sheets, LP
    Weiss, B
    Mileson, B
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 : 79 - 91
  • [26] Considering developmental neurotoxicity in vitro data for human health risk assessment using physiologically-based kinetic modeling: deltamethrin case study
    Maass, Christian
    Schaller, Stephan
    Dallmann, Andre
    Bothe, Kathrin
    Mueller, Dennis
    TOXICOLOGICAL SCIENCES, 2023, 192 (01) : 59 - 70
  • [27] Assessment of poly (hexamethylenebicyanoguanide-hexamethylenediamine) hydrochloride-induced developmental neurotoxicity via oxidative stress mechanism: Integrative approaches with neuronal cells and zebrafish
    Oh, Ha-Na
    Yoo, Donggon
    Park, Seungmin
    Lee, Sangwoo
    Kim, Woo-Keun
    JOURNAL OF HAZARDOUS MATERIALS, 2024, 465
  • [28] Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: Pharmacokinetic and pharmacodynamic considerations
    Dorman, DC
    Allen, SL
    Byczkowski, JZ
    Claudio, L
    Fisher, JE
    Fisher, JW
    Harry, GJ
    Li, AA
    Makris, SL
    Padilla, S
    Sultatos, LG
    Mileson, BE
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 : 101 - 111
  • [29] A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures
    Vorhees, Charles V.
    Sprowles, Jenna N.
    Regan, Samantha L.
    Williams, Michael T.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 354 : 176 - 190
  • [30] Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials
    Stone, Vicki
    Johnston, Helinor J.
    Balharry, Dominique
    Gernand, Jeremy M.
    Gulumian, Mary
    RISK ANALYSIS, 2016, 36 (08) : 1538 - 1550